Product inquiry request
Which of the following best describes your inquiry?
Submit Your Inquiry
If you have questions about any of the topics below, please click the link to visit the related Adaptive Biotechnologies webpage to learn more.
CLONOSEQ NGS-Based MRD TECHNOLOGYCLONOSEQ CLINICAL DATACLONOSEQ REPORTS
If you have additional questions, please fill out the Medical Information request form below:
Submit Your Inquiry
If you have questions about any of the topics below, please click the link to visit the related Adaptive Biotechnologies webpage to learn more.
ORDERING CLONOSEQCLONOSEQ REPORTS
Our Clinical Services team can also help answer your questions. To speak with a Clinical Services Specialist, please email dxsupport@adaptivebiotech.com.
If you have additional questions, please fill out the Medical Information request form below:
Review Support Materials or Give Us a Call
If you have questions about the information provided in a clonoSEQ report, please visit our Reports page.
If you have additional questions about a patient report or results, please contact our Clinical Services team by emailing dxsupport@adaptivebiotech.com.
Submit Your Inquiry
If you are interested in incorporating the clonoSEQ® Assay into an investigator-sponsored trial (IST), please contact us by filling out the form below.
Submit Your Inquiry
If you have a question about a topic not covered elsewhere on this site, please contact us by filling out the form below.
This page is intended for use by healthcare professionals outside of the United States.
The clonoSEQ Assay B-cell Reagent Set is an in vitro diagnostic that identifies and quantifies rearranged B-cell receptor gene sequences in DNA extracted from blood and bone marrow.
It is a manual test that determines measurable/minimal residual disease (MRD) and monitors changes in disease burden during and after treatment in B-cell malignancies. The test is indicated for use by qualified healthcare professionals for clinical decision-making and in conjunction with other clinicopathological features.
The clonoSEQ Assay is being utilized for a variety of investigator-sponsored clinical trials in B-cell lymphoid cancers. If you are interested in learning more about use of clonoSEQ in your own trials, contact dxsupport@adaptivebiotech.com.